Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company committed to the discovery and development of novel therapeutics to treat cystic fibrosis, or CF, through theratyping, or the process of matching modulators to individual response to treatment regardless of CFTR mutations. CF is a disease caused by defects in the function. ... More >>
Copyright West LLC. Minimum 15 minutes delayed.